Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein-Reference-Cited by-同舟云学术

Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein

Published:2007-07-31 Issue:2 Volume:57 Page:233-246
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Stieglmaier Julia,Bremer Edwin,Kellner Christian,Liebig Tanja M.,ten Cate Bram,Peipp Matthias,Schulze-Koops Hendrik,Pfeiffer Matthias,Bühring Hans-Jörg,Greil Johann,Oduncu Fuat,Emmerich Bertold,Fey Georg H.,Helfrich Wijnand

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-007-0370-8.pdf

Reference58 articles.

1. Almasan A, Ashkenazi A (2003) Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 14:337

2. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104:155

3. Barbin K, Stieglmaier J, Saul D, Stieglmaier K, Stockmeyer B, Pfeiffer M, Lang P, Fey GH (2006) Influence of variable N-glycosylation on the cytolytic potential of chimeric CD19 antibodies. J Immunother 29:122

4. Baum W, Steininger H, Bair HJ, Becker W, Hansen-Hagge TE, Kressel M, Kremmer E, Kalden JR, Gramatzki M (1996) Therapy with CD7 monoclonal antibody TH-69 is highly effective for xenografted human T-cell ALL. Br J Haematol 95:327

5. Benedict CA, MacKrell AJ, Anderson WF (1997) Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay. J Immunol Methods 201:223

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Targeting Carriers in Antibody-Drug Conjugates;Antibody-Drug Conjugates and Cellular Metabolic Dynamics;2023

2. TRAIL in the Treatment of Cancer: From Soluble Cytokine to Nanosystems;Cancers;2022-10-19

3. Improving Targeted Delivery and Antitumor Efficacy with Engineered Tumor Necrosis Factor-Related Apoptosis Ligand-Affibody Fusion Protein;Molecular Pharmaceutics;2021-09-20

4. Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo;Journal of Clinical Medicine;2021-06-15

5. The MUDENG Augmentation: A Genesis in Anti-Cancer Therapy?;International Journal of Molecular Sciences;2020-08-04